Candel Therapeutics Inc’s recent filing unveils that its Chief Scientific Officer Barone Francesca unloaded Company’s shares for reported $0.11 million on Jan 08 ’25. In the deal valued at $8.22 per share,13,673 shares were sold. As a result of this transaction, Barone Francesca now holds 124,207 shares worth roughly $0.97 million.
Then, Schoch Charles sold 9,971 shares, generating $81,944 in total proceeds. Upon selling the shares at $8.22, the insider now owns 52,549 shares.
Before that, Tak Paul Peter sold 21,172 shares. Candel Therapeutics Inc shares valued at $173,996 were divested by the Chief Executive Officer at a price of $8.22 per share. As a result of the transaction, Tak Paul Peter now holds 273,616 shares, worth roughly $2.13 million.
H.C. Wainwright initiated its Candel Therapeutics Inc [CADL] rating to a Buy in a research note published on December 02, 2022; the price target was $11. A number of analysts have revised their coverage, including BMO Capital Markets’s analysts, who began to cover the stock in mid November with a ‘”an Outperform”‘ rating. UBS began covering CADL with “Buy” recommendation on August 23, 2021. Jefferies started covering the stock on August 23, 2021. It rated CADL as “a Buy”.
Price Performance Review of CADL
On Monday, Candel Therapeutics Inc [NASDAQ:CADL] saw its stock fall -5.01% to $7.77. Over the last five days, the stock has lost -15.73%. Candel Therapeutics Inc shares have fallen nearly -10.48% since the year began. Nevertheless, the stocks have risen 463.04% over the past one year. While a 52-week high of $14.60 was reached on 01/06/25, a 52-week low of $1.16 was recorded on 01/13/25. SMA at 50 days reached $6.22, while 200 days put it at $6.56.
Levels Of Support And Resistance For CADL Stock
The 24-hour chart illustrates a support level at 7.26, which if violated will result in even more drops to 6.76. On the upside, there is a resistance level at 8.31. A further resistance level may holdings at 8.86. The Relative Strength Index (RSI) on the 14-day chart is 50.77, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.40, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 82.59%. Stochastics %K at 40.68% indicates the stock is a holding.
How much short interest is there in Candel Therapeutics Inc?
A steep rise in short interest was recorded in Candel Therapeutics Inc stocks on 2024-10-31, growing by 0.19 million shares to a total of 1.78 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 1.59 million shares. There was a rise of 10.79%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on August 23, 2021 when Credit Suisse began covering the stock and recommended ‘”an Outperform”‘ rating along with a $15 price target.
